Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

15.47 -0.02 (-0.10%)
Streaming Delayed Price Updated: 2:23 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dynavax Technologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Valneva Initiates Rolling Submission For COVID19 Vaccine Candidate In UK ↗
Valneva SE (NASDAQ: VALN) has commenced rolling submission for its COVID-19 vaccine candidate with the Medicines and Healthcare products Regulatory Agency (MHRA)... 
Via Benzinga
News headline image
Return on Capital Employed Overview: Dynavax Technologies ↗
Pulled from Benzinga Pro data Dynavax Technologies (NASDAQ:DVAX) posted Q2 earnings of $9.17 million, an increase from Q1 of 67.85%. Sales dropped to $52.77 million, a 36.68%... 
Via Benzinga
News headline image
Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines. 
Via The Motley Fool
News headline image
Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now ↗
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet. 
Via The Motley Fool
News headline image
Why Dynavax, Novavax, and Sorrento Soared This Week ↗
There were different reasons behind each of these COVID-19 vaccine stocks' big gains. 
Via The Motley Fool
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021 ↗
Upgrades According to Wolfe Research, the prior rating for The AES Corp (NYSE: 
Via Benzinga
News headline image
28 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to acquire exclusive rights for assignment of... 
Via Benzinga
News headline image
Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week ↗
Each vaccine stock had its own separate catalyst. 
Via The Motley Fool
News headline image
10 Biggest Price Target Changes For Thursday ↗
Keybanc boosted the price target for HubSpot, Inc. (NYSE: 
Via Benzinga
News headline image
Why Dynavax Stock Has Jumped 11% So Far This Week ↗
The company inked a significant supply deal for its vaccine adjuvant. 
Via The Motley Fool
News headline image
Clover, Dynavax Ink Commercial Supply Agreement For CpG 1018 Adjuvant ↗
Clover Biopharmaceuticals and Dynavax Technologies Corporation (NASDAQ: DVAX) have executed the commercial supply agreement of Dynavax's CpG 1018TM... 
Via Benzinga
News headline image
Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today ↗
The declines appear to be caused simply by volatility that's common with small biotech stocks. 
Via The Motley Fool
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
News headline image
Valneva Concludes Recruitment for COVID-19 Vaccine Candidate Trial ↗
Privately-held Valneva SE has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001... 
Via Benzinga
News headline image
Why Dynavax Stock Is Rising Today ↗
The company signed a key deal to market its hepatitis B vaccine in Germany. 
Via The Motley Fool
News headline image
Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany ↗
Dynavax Technologies Corporation (NASDAQ: DVAX) has entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISAV... 
Via Benzinga
News headline image
India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters ↗
Johnson and Johnson (NYSE: JNJ) has joined hands with India-based Biological E Limited to manufacture its COVID-19 vaccine, alongside Biological E's COVID-19... 
Via Benzinga
News headline image
Why Dynavax Technologies Stock Is Sinking Again Today ↗
The company announced the pricing of its senior convertible notes offering. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
News headline image
Why Dynavax Stock Is Nosediving Today ↗
The biotech announced a senior convertible notes offering. 
Via The Motley Fool
News headline image
64 Biggest Movers From Yesterday ↗
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3.... 
Via Benzinga
News headline image
40 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares jumped 64.2% to $3.4962 on above-average news. Obalon Therapeutics, Inc. (NASDAQ: OBLN) gained 35% to $2.97. Cue... 
Via Benzinga
News headline image
Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript ↗
DVAX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
How Dynavax Demolished Expectations With Its Q1 Results ↗
The company's hepatitis B vaccine wasn't its key growth driver. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.